Biomarkers in Pulmonary Hypertension

Area of Science:

• Biomedical science
• Cardiology
• Pulmonology

Background:

• Biomarkers are essential for managing pulmonary hypertension (PH).
• They provide insights into risk assessment, disease progression, and therapy response.
• Understanding PH requires assessing various molecular pathways and organ systems.

Purpose of the Study:

• To highlight the role of biomarkers in comprehensive pulmonary hypertension management.
• To emphasize the importance of a multiparametric approach in assessing PH.
• To underscore PH as a systemic condition beyond cardiorespiratory illness.

Main Methods:

• Review of current literature on biomarkers in PH.
• Analysis of molecular pathways implicated in PH pathophysiology.
• Evaluation of multiparametric biomarker strategies.

Main Results:

• Biomarkers are vital for risk stratification, monitoring disease progression, and evaluating treatment efficacy in PH.
• Peripheral venous blood biomarkers reflect activated molecular pathways.
• A multiparametric approach offers comprehensive clinical information, especially in advanced PH stages.

Conclusions:

• Biomarkers are indispensable tools for managing pulmonary hypertension.
• A multiparametric biomarker strategy is preferred for a holistic understanding of PH.
• Pulmonary hypertension is a systemic disease with multi-organ involvement.